How Big Pharma Profits from Swine Flu

[guest]

Once spurned by drugmakers as low-margin and risky, vaccines to fight diseases such as H1N1 are now a growing business for Novartis and others


More...

Toggle signature
||||| Mentor Group Access Now! |||||